(Q38175120)

30 August 2017

title

Stereotactic body radiotherapy: a critical review for nonradiation oncologists (English)

1 reference

adaptive radiation therapy

30 August 2017

main subject

0 references

author

Christopher R. Kelsey

object named as

Christopher R Kelsey

2

0 references

John P. Kirkpatrick

object named as

John P Kirkpatrick

1

0 references

author name string

Manisha Palta

3

1 reference

30 August 2017

Alvin R Cabrera

4

1 reference

30 August 2017

Joseph K Salama

5

1 reference

30 August 2017

Pretesh Patel

6

1 reference

30 August 2017

Bradford A Perez

7

1 reference

30 August 2017

Jason Lee

8

1 reference

30 August 2017

Fang-Fang Yin

9

1 reference

30 August 2017

language of work or name

English

0 references

publication date

30 December 2013

1 reference

30 August 2017

1 reference

30 August 2017

volume

120

1 reference

30 August 2017

issue

7

1 reference

30 August 2017

page(s)

942-954

1 reference

Inauguration of radiotherapy as a new scientific speciality by Leopold Freund 100 years ago.

30 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

Radiotherapy and radiosurgery for tumors of the central nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

Universal survival curve and single fraction equivalent dose: useful tools in understanding potency of ablative radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

Engaging the vascular component of the tumor response

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

Stereotactic radiosurgery and stereotactic body radiation therapy: an overview of technical considerations and clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

kV cone-beam CT-based IGRT: a clinical review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

Quality and safety considerations in stereotactic radiosurgery and stereotactic body radiation therapy: Executive summary

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

Task Group 142 report: quality assurance of medical accelerators

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

Stereotactic body radiation therapy: the report of AAPM Task Group 101.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

Quality assurance for image-guided radiation therapy utilizing CT-based technologies: a report of the AAPM TG-179.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

Prospective, risk-adapted strategy of stereotactic body radiotherapy for early-stage non-small-cell lung cancer: results of a Phase II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

Stereotactic body radiation therapy for inoperable early stage lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

Dosimetric evaluation of heterogeneity corrections for RTOG 0236: stereotactic body radiotherapy of inoperable stage I-II non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

Dose-response for stereotactic body radiotherapy in early-stage non-small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

Radiographic changes after lung stereotactic ablative radiotherapy (SABR)--can we distinguish recurrence from fibrosis? A systematic review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

Radiation injury of the lung after stereotactic body radiation therapy (SBRT) for lung cancer: a timeline and pattern of CT changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

Positron-emission tomography CT to identify local recurrence in stage I lung cancer patients 1 year after stereotactic body radiation therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

Chest wall volume receiving >30 Gy predicts risk of severe pain and/or rib fracture after lung stereotactic body radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

Radiation-induced rib fractures after hypofractionated stereotactic body radiation therapy of non-small cell lung cancer: a dose- and volume-response analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

Chest wall pain and rib fracture after stereotactic radiotherapy for peripheral non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

Obesity increases the risk of chest wall pain from thoracic stereotactic body radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

Acute skin toxicity following stereotactic body radiation therapy for stage I non-small-cell lung cancer: who's at risk?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

Brachial plexopathy from stereotactic body radiotherapy in early-stage NSCLC: dose-limiting toxicity in apical tumor sites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

Analysis of radiation-induced liver disease using the Lyman NTCP model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

Stereotactic body radiotherapy for primary hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

Phase I feasibility trial of stereotactic body radiation therapy for primary hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

Long-term effect of stereotactic body radiation therapy for primary hepatocellular carcinoma ineligible for local ablation therapy or surgical resection. Stereotactic radiotherapy for liver cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

Stereotactic radiotherapy of hepatocellular carcinoma: preliminary results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

Stereotactic body radiation therapy for primary and metastatic liver tumors: A single institution phase i-ii study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

Evaluation of response after stereotactic body radiotherapy for hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

Dose-escalation study of single-fraction stereotactic body radiotherapy for liver malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

Stereotactic radiation therapy of liver metastases: update of the initial phase-I/II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

Phase II study on stereotactic body radiotherapy of colorectal metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

Phase I study of individualized stereotactic body radiotherapy of liver metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

Stereotactic body radiation therapy for colorectal liver metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

Univariate analysis of factors correlated with tumor control probability of three-dimensional conformal hypofractionated high-dose radiotherapy for small pulmonary or hepatic tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

Survival after hepatic resection for colorectal metastases: a 10-year experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

The emergent role of focal liver ablation techniques in the treatment of primary and secondary liver tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: a randomized EORTC Intergroup phase II study (EORTC 40004).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

Radiotherapy for liver metastases: a review of evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

Randomized trial of short- versus long-course radiotherapy for palliation of painful bone metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

Single fraction conventional external beam radiation therapy for bone metastases: a systematic review of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

Radiotherapy and radiosurgery for metastatic spine disease: what are the options, indications, and outcomes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

Impact of collimator leaf width and treatment technique on stereotactic radiosurgery and radiotherapy plans for intra- and extracranial lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

Prospective evaluation of spinal reirradiation by using stereotactic body radiation therapy: The University of Texas MD Anderson Cancer Center experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

Clinical results of retreatment of vertebral bone metastases by stereotactic conformal radiotherapy and intensity-modulated radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

Recursive partitioning analysis index is predictive for overall survival in patients undergoing spine stereotactic body radiation therapy for spinal metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

Radiation dose-volume effects in the spinal cord.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

Spinal cord tolerance for stereotactic body radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

Risk of fracture after single fraction image-guided intensity-modulated radiation therapy to spinal metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

Local disease control after decompressive surgery and adjuvant high-dose single-fraction radiosurgery for spine metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

Postoperative radiosurgery for malignant spinal tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

Oligo- and polymetastatic progression in lung metastasis(es) patients is associated with specific microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

Surgical resection of hepatic and pulmonary metastases from colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

Pulmonary metastases from soft tissue sarcoma: analysis of patterns of diseases and postmetastasis survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

Outcomes of adrenalectomy for isolated synchronous versus metachronous adrenal metastases in non-small-cell lung cancer: a systematic review and pooled analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

Focal, high dose, and fractionated modified stereotactic radiation therapy for lung carcinoma patients: a preliminary experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

Stereotactic body radiation therapy for adrenal metastases: a retrospective review of a noninvasive therapeutic strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

Oligometastases treated with stereotactic body radiotherapy: long-term follow-up of prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

Stereotactic body radiotherapy for multisite extracranial oligometastases: final report of a dose escalation trial in patients with 1 to 5 sites of metastatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

Stereotactic body radiation therapy for management of spinal metastases in patients without spinal cord compression: a phase 1-2 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

Stereotactic body radiotherapy for colorectal liver metastases: a pooled analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

Stereotactic body radiation therapy using three fractions for isolated lung recurrence from colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

Comparison of outcomes in patients with stage III versus limited stage IV non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

Radical treatment of non-small-cell lung cancer patients with synchronous oligometastases: long-term results of a prospective phase II trial (Nct01282450).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

Hypofractionated image-guided radiation therapy for patients with limited volume metastatic non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

Oligometastatic breast cancer treated with curative-intent stereotactic body radiation therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

Safety and feasibility of image-guided robotic radiosurgery for patients with limited bone metastases of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

Stereotactic body radiotherapy for pulmonary metastases from soft-tissue sarcomas: excellent local lesion control and improved patient survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

Stereotactic body radiotherapy for the treatment of oligometastatic renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

Stereotactic body radiation therapy for melanoma and renal cell carcinoma: impact of single fraction equivalent dose on local control

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

Stereotactic body radiotherapy for primary management of early-stage, low- to intermediate-risk prostate cancer: report of the American Society for Therapeutic Radiology and Oncology Emerging Technology Committee.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

Pushing the limits of radiation therapy for prostate cancer: where do we go next?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

Palliative radiotherapy for bone metastases: an ASTRO evidence-based guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

ACR Appropriateness Criteria® non-spine bone metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

Combining radiotherapy and cancer immunotherapy: a paradigm shift

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

Efficacy and cost-effectiveness analysis of external beam and stereotactic body radiation therapy in the treatment of spine metastases: a matched-pair analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

Cost-effectiveness of stereotactic body radiation therapy versus surgical resection for stage I non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

Stereotactic radiosurgery and stereotactic body radiation therapy cost-effectiveness results

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

Cost-effectiveness analysis of stereotactic body radiation therapy versus intensity-modulated radiation therapy: an emerging initial radiation treatment option for organ-confined prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

Robotic image-guided stereotactic radiotherapy, for isolated recurrent primary, lymph node or metastatic prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

The linear-quadratic model is inappropriate to model high dose per fraction effects in radiosurgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

The Linear-Quadratic Model Is Inappropriate to Model High Dose per Fraction Effects in Radiosurgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

Guest Editor's Introduction to QUANTEC: A Users Guide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

Preliminary result of stereotactic body radiotherapy as a local salvage treatment for inoperable hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

Survival after Hepatic Resection for Metastatic Colorectal Cancer: Trends in Outcomes for 1,600 Patients during Two Decades at a Single Institution

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

Outcomes after Resection of Synchronous or Metachronous Hepatic and Pulmonary Colorectal Metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

7 January 2021

Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: four-year results of a prospective phase II study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

7 January 2021

Stereotactic body radiation therapy for early stage non-small cell lung cancer: results of a prospective trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

7 January 2021

Accelerated hyperfractionated hepatic irradiation in the management of patients with liver metastases: results of the RTOG dose escalating protocol

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

7 January 2021

Stereotactic High Dose Fraction Radiation Therapy of Extracranial Tumors Using An Accelerator: Clinical experience of the first thirty-one patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

7 January 2021

Sequential Phase I and II Trials of Stereotactic Body Radiotherapy for Locally Advanced Hepatocellular Carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

7 January 2021

Stereotactic body radiation therapy with or without transarterial chemoembolization for patients with primary hepatocellular carcinoma: preliminary analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

7 January 2021

Phase I Study of Individualized Stereotactic Body Radiotherapy for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

7 January 2021

Hypofractionated stereotactic body radiation therapy (SBRT) for limited hepatic metastases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

7 January 2021

Phase I dose-escalation study of stereotactic body radiotherapy in patients with hepatic metastases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

7 January 2021

Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

7 January 2021

Stereotactic radiotherapy of primary liver cancer and hepatic metastases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

7 January 2021

Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Française de Chirurgie

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

7 January 2021

Surgical treatment of spinal cord compression in kidney cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

7 January 2021

Stereotactic radiosurgery for spinal metastases from renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

7 January 2021

Partial volume tolerance of the spinal cord and complications of single-dose radiosurgery

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

7 January 2021

Single-fraction radiosurgery for the treatment of spinal breast metastases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

7 January 2021

https://api.crossref.org/works/10.1002%2FCNCR.28515

1 reference

7 January 2021

Liver resection for colorectal metastases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

7 January 2021

Resection of brain metastases from sarcoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

7 January 2021

Pulmonary resection of metastatic renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

7 January 2021

Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

7 January 2021

Long term disease-free survival resulting from combined modality management of patients presenting with oligometastatic, non-small cell lung carcinoma (NSCLC)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

7 January 2021

Stereotactic body radiotherapy for oligometastatic lung tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

7 January 2021

Efficacy of eradicative radiotherapy for limited nodal metastases detected with choline PET scan in prostate cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

7 January 2021

Phase 1 clinical trial of stereotactic body radiation therapy concomitant with neoadjuvant chemotherapy for breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

7 January 2021

Preoperative single fraction partial breast radiotherapy for early-stage breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

7 January 2021

Extracranial stereotactic radiotherapy for primary and metastatic renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28515

7 January 2021

Identifiers

DOI

10.1002/CNCR.28515

1 reference

30 August 2017

1 reference